Rabies Diagnostics Market 2023 Size, Share, Industry Trends, Business Revenue Forecast Statistics And Growth Prospective

Rabies Diagnostics Market Overview

Global rabies diagnostics market is growing pervasively, mainly due to the increasing prevalence of rabies. Besides, spreading awareness of diagnostic procedures is driving the growth of the market. Also, rising research and development activities by non-profit organizations alongside, the aggressive strategies by top players such as mergers & acquisition, expansion, and collaboration for the development of new products and launches are accelerating the growth of the market on a global level.

According to a leading research firm Market Research Future (MRFR), the global rabies diagnostics market had created a valuation of USD 1964 MN in 2017 which is expected to further appreciate at a CAGR of 4.36% throughout the forecast period (2018–2023). In its analysis, MRFR asserts that the market will perceive phenomenal accruals by 2023. The major outburst of the rabies virus, mainly in various regions across the globe is a significant driving force for the market.

Governments, across the world, have taken up various initiatives to spread awareness about rabies viruses. They are introducing multiple diagnostic procedures in the hospitals, allotting significant budgetary programs. These factors, as a result, substantiate the growth of the market, commutatively. Simultaneously, diligent efforts put in by vendors and pharma companies to develop novel diagnostic devices foster the growth of the market. 

Conversely, high costs associated with the diagnostic and vaccination is acting as a significant headwind to the growth of the market. Also, the growing number of new entrants with absolutely limited medical equipment business history, and a considerable price gap between the top players and small unorganized players are impeding the market growth.

Nevertheless, continuous technological advancements, rising demand for quick test results would support the growth of the market. Furthermore, increasing governmental endeavors to spread awareness towards the viruses are estimated to propel the market from 2018 to 2023.

Global Rabies Diagnostics Market – Segments

The report is segmented into four dynamics to widen the scope of understanding, 

By Method: Fluorescent Antibody Test (FAT), Immunohistochemical Test, Amplification Methods, Histologic Examination, and Serology Tests, among others.

By Technology: ELISA/Immunohistochemistry, Chromatography Techniques, and PCR, among others.

By End-user: Hospitals, Diagnostic Centers, and Cancer Palliative Care Clinics, among others.

By Regions: Europe, North America, Asia Pacific, and the Rest-of-the-World. 

Global Rabies Diagnostics Market – Geographical Analysis

The Asia Pacific has the maximum market coverage in the global rabies diagnostics market. Despite the several adversaries, the APAC market is surging rapidly due to the ongoing programs to increase awareness among people, developments in healthcare, and the growing per capita healthcare expenditure in the region.

With the rising investments in healthcare and expansions by market players, the region is expected to continue its dominance over the global rabies diagnostics market throughout the forecast period. Also, Government support for R&D focused on the development and adoption of advanced technology alongside, the availability of best treatment options in India and China are substantiating the regional market growth.

North America is the second-largest market for rabies diagnostics accounting for a substantial market share. Rising strategic alliances between significant players and well-spread awareness about rabies drive the growth of the market in the region. Additionally, the involvement of non-profit organization to control the disease and well-established healthcare infrastructure would speed up the growth of the regional market. 

Also, the awareness towards the advantages of the test methods and the augmented governmental spending for R&D activities to develop novel diagnostic methods propel the growth of the regional market. Furthermore, technological advancements transpired into the field of rabies diagnostics driving forces behind the growth of the market in the region.

The rabies diagnostics market in Europe is multiplying. The market growth in this region attributes to the government funding, well-established healthcare sector, and support from the government for research and development. European governments spend substantially on diagnostic tests, innovations, and treatments for the virus.

Global Rabies Diagnostics Market – Competitive Analysis

Highly competitive, the Rabies diagnostics market appears to be widely expanded with the presence of many players. Expected extensions in products & services would drive the competition in the market, intensifying it further. This market demonstrates pretty good growth prospects that are expected to attract new entrant, also introducing the market with fierce competition. 

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/rabies-diagnostics-market-7796

Rabies Diagnostics Market Major Players: 

Players leading the global rabies diagnostics market are Merck KGaA, Bio-Rad Laboratories, Inc., Aviva Systems Biology Corporation, Demeditec Diagnostics GmbH, Creative Diagnostics, Abbexa Ltd., BioNote, Inc., Norgen Biotek Corp., Express Biotech International Inc., BioGen Technologies, and MyBioSource.com, among others. 

Rabies Diagnostics Industry/ Innovations/ Related News 

July 03, 2019 ----- Ceva Sante Animale S.A. (France), announced the successful completion of the acquisition of veterinary biopharmaceutical and research and development activities of IDT Biologika GmbH (Germany). The acquisition would position Ceva closer to its 2020 growth objective of a 50:50 bio-pharma split. The product portfolio would be added to Ceva's portfolio soon. A new innovation center focused on swine vaccines would be created within IDT's existing Dessau site.

IDT's strong range of swine vaccines would strengthen Ceva's presence in this segment. The deal would boost Ceva's Veterinary Public Health offer in rabies control, with Rabitec, a rabies vaccine that can be used as oral immunization of foxes and other species. This would play a crucial role in campaigns focused on the successful eradication of rabies worldwide.

Urinary Catheters Market Share, Global Overview, Business Growth, Sales Revenue, Competitive Landscape And Industry Expansion Strategies 2023

Urinary Catheters Market Analysis  

The urinary catheters market is anticipated to grow at a 7.8% CAGR between 2018-2023, states the latest Market Research Future (MRFR) report. A urinary catheter, simply put, is a tube that is placed in the human body for draining and collecting urine from the bladder. It comes in different types, sizes, and materials. A catheter is suggested by a doctor if a person has urinary retention, has urinary incontinence, or cannot control when they urinate.  

Various factors are propelling the urinary catheters market growth. Such factors, as per the latest Market Research Future report, include increasing awareness about the benefits of catheterization among the populace, increasing geriatric population, rising rates of obesity, growing preference for self-catheterization, and single-use catheters, and favorable reimbursement scenario. Additional factors pushing the growth of the urinary catheters market include rising number of surgical procedures worldwide, increasing incidence of urinary incontinence, rising incidence of bladder cancer, kidney, as well as other renal diseases, government support to offer the public with affordable medical facilities, rising spending on healthcare, and rapid economic growth.  

On the contrary, social stigma, disposal concerns related to used catheters, patient incompliance, incidences of infection in the urinary tract, and availability of alternatives are factors that may deter the catheter market.  

Urinary Catheters Market Segmentation 

The Market Research Future report provides an all-inclusive segmental analysis of the urinary catheters market on the basis of end user, indication, gender, product, and type. 

By type, the urinary catheters market is segmented into uncoated catheters and coated catheters. Of these, coated catheters will lead the market during the forecast period. They ensure more comfortable and easier insertion, thus offering better patient satisfaction and cutting down the risks of urethral damage.  

By gender, the urinary catheters market is segmented into female urinary catheters and male urinary catheters.  

By product, the urinary catheters market is segmented into external catheters, indwelling catheters, and intermittent catheters. Of these, the intermittent catheters will dominate the market during the forecast period. 

By indication, the urinary catheters market is segmented into general surgery, urinary incontinence, spinal cord injuries, and benign prostatic hyperplasia. Of these, urinary incontinence will have the maximum share in the market during the forecast period due to the huge population suffering from this condition worldwide.  

By end user, the urinary catheters market is segmented into research organizations and academic institutes, hospitals and clinics, and others.  

Urinary Catheters Market Regional Analysis 

By region, the urinary catheters market report covers the latest trends and growth opportunities across the Americas, the Middle East and Africa, Europe, and the Asia Pacific. Of these, the Americas will dominate the market during the forecast period. Various factors propelling the urinary catheters market growth in the region include the presence of key market players in the region, high domestic income, and increasing incidence of urinary tract infections that are catheter-associated.  

The urinary catheters market in Europe will have the second-largest share during the forecast period. Various factors propelling the urinary catheters market growth in the region include the accessibility of funds for research coupled with the presence of a strong academic and research base.  

The urinary catheters market in the APAC region will grow at the fastest pace during the forecast period for the growing focus of leading market players in this region and increasing patient population.  

The urinary catheters market in the MEA will have a small share during the forecast period for the increasing number of initiatives undertaken by the government for the healthcare industry. 

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/urinary-catheters-market-one-7600

Urinary Catheters Market Key Players 

Notable players profiled in the urinary catheters market report include Rochester Medical Corporation, Hollister Incorporated, Cook Medical, Bactiguard Holding, Wellspect Healthcare (A Subsidiary of Dentsply IH Ltd.), C.R. Bard, Inc., Medtronic, Teleflex, Terumo Europe NV, Medloyd Healthcare, DISA Vascular, B. Braun Melsungen AG, Werkomed Pty Ltd, ConvaTec Group PLC, Coloplast A/S, and Boston Scientific Corporation.   

Urinary Catheters Industry News  

November 2019: Leading developer of urinary smart catheter fixations, CATHETRIX has recently signed an agreement with the global distributor of medical products, Pro-Lab Diagnostics for FoleySafe catheter securement device distribution in the United Kingdom, the United States, and Canada. FolySafe is the first catheter stabilizer that actively prevents possible damages to the urethra and bladder from the accidental extraction of the urinary catheter. 

Biologics Market 2020 Size, Share Leading Growth Drivers, Emerging Audience, Emerging Factors, Leading Growth Drivers, Segments, Sales, Profits And Future Outlook

Biologics Market Overview

Biologics also referred to as a biologic drug, is generally produced from living organisms and contain components of living organisms. Biologics can also be derived from animal, human, or microorganisms with the help of biotechnological techniques. It comprises products like blood and blood components, vaccines, somatic cells, allergenic, tissues, gene therapy, and recombinant therapeutic proteins. The global biologics market, as per a report by Market Research Future (MRFR) is touted to register a CAGR of 6.95%, surpassing a valuation of USD 285,520.4 million during the forecast period (2018-2023).

The biologics market is highly driven by the increasing capital investment from the major industry players, increasing incidences of chronic diseases, higher acceptability and surging demand for innovative therapies, and loss of patient exclusivity of leading biologic drugs. The advent of targeted therapies and surging adoption of patient-centric personalized medicine are some of the primary growth stimulants of the biologics market across the globe. Factors involved in heterologous gene expression and protein production, along with the increasing understanding of the cell physiology and stress have further empowered the use of living factories.

Soaring adoption of biopharmaceuticals over chemically synthesized molecules will augment revenue generation globally. Moreover, the existence of multiple metabolic disorders, which can be treated with the use of biologics will encourage the market demand across the globe.

On the contrary, deployment of biosimilars will restrict the market growth in the foreseeable future. Moreover, strict regulatory mandates for the approval of biologics will deter its growth in the years to come.

Global Biologics Market: Segmental Analysis

The global biologics market has been segmented on the basis of product, disease indication, and manufacturing.

By product, the biologics market is segmented into interleukins, monoclonal antibody, growth factors, vaccines, gene therapy, and others. Of these, the monoclonal antibody segment held 33% of the market share in 2017. The segment will surpass a valuation of USD 92,597.4 million by the end of 2023, registering a CAGR of 3.44% due to the rising use of monoclonal antibodies to improve the immunity system of the body.

By disease indication, the market is segmented into cancer, psoriasis/psoriatic arthritis, rheumatoid arthritis, diabetes, and others. Of these, cancer held 19.2% of the market share in 2018. Meanwhile, the rheumatoid arthritis segment is likely to gain prominence due to the rapid approval of several drugs by the regulatory agencies.

The manufacturing segment comprises sourced and in-house. Of these, the sourced segment will expand at a rapid pace due to the existence of pharmaceutical companies in developing nations, which can research formulations at a reasonable price.

Biologics Market Regional Frontiers

Geographically, the biologics market spans across Europe, America, Asia Pacific, and the Middle East & Africa.

Considering the global scenario, the Asia Pacific is predicted to register the highest CAGR of 5.53%. The growth can be credited to the existence of several contract manufacturing organizations. Growth in geriatric populace, coupled with the changing healthcare sector, are considered some of the primary growth stimulants of the regional market. In this region, India is considered to be a major contributor to the market’s revenue, mainly due to the huge strides in manufacturing biologics.

America will command a large share of the biologics market, mainly due to the extensive adoption of manufacturing technologies, coupled with strong economic growth of Canada and the U.S. High investments in new facilities in order to produce drugs for clinical trials will augment the market growth in the foreseeable future. In this region, North America is likely to lead the market due to the rising prevalence of chronic diseases, existence of well-established pharmaceutical companies, and rising number of biotech companies. The presence of industry bigshots like Bristol-Myers Squibb, Johnson & Johnson, AbbVie Inc., and others are making the biologics market more accessible in the U.S.

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/biologics-market-1339

Biologics Industry Updates

March 2019: Crescendo Biologics Ltd., the drug developer of targeted T-cell improving therapeutics, has recently declared that they have won the award for Life Science Innovation at the 2019 Business Weekly Awards.

Biologics Market Competitive Dashboard

The top players operating in the biologics market include Pfizer Inc. (U.S.), AbbVie, Inc. (U.S.), Novartis AG (Switzerland), AstraZeneca (U.K.), Bayer AG (Germany), F. Hoffman-La Roche AG (Switzerland), Sanofi (France), Amgen (U.S.), GlaxoSmithKline Plc (U.K.), Eli Lilly and Company (U.S.), and others.

Dental 3D Printing Market Size, Share, Key Findings, Segmentation, Development Trends, Revenue

Dental 3D Printing Market Insight

Global dental 3D printing market is expected to exhibit a robust 24.5% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The report presents a detailed analysis of the global dental 3D printing market by providing readers with a comprehensive overview of the market’s historical trajectory. The leading drivers and restraints affecting the global Dental 3D Printing Market are assessed in detail in the report. The historical impact of these drivers and restraints is analyzed in context of the current impact of these factors and projections are made for the likely impact of these drivers and restraints over the forecast period. Various components of the global dental 3D printing market are also studied in the report and projections are made for the growth trajectory of each distinct component.

The various segments and sub-segments within the global dental 3D printing market are studied in detail in the report. The study also makes a detailed analysis of the major players operating in the global dental 3D printing market and provides a detailed look at the various competitive strategies employed by players in the global dental 3D printing market. Likely future conditions with respect to the competitive landscape of the market are also explained in detail in the report.

The growing dental healthcare sector is likely to be the major driver for the global dental 3D printing market. Due to the growing prevalence of dental caries and other dental conditions, the dental healthcare sector has grown at a rapid pace over the last few years. The increasing demand for innovative solutions in the dental healthcare sector has also driven the demand for dental 3D printing. Dental 3D printing can be used to print out crowns, bridges, dentures, and other dental implements at low costs and effort. This has driven the adoption of 3D printing in the dental healthcare sector. The increasing complexity and sophistication of 3D printing technology is also responsible for the growing adoption of 3D printing in dental healthcare, as increasingly complicated structures can be easily printed out via 3D printing, reducing the efforts required of dentists and dental technicians. Increasing demand for precise fitting in dental implements is likely to result in an increasing demand from the dental 3D printing market over the forecast period.

Dental 3D Printing Market Competitive Analysis:

Leading players in the global dental 3D printing market include Roland DG, Asiga, Rapid Shape GmbH, EOS GmbH Electro Optical Systems, Concept Laser GmbH, Carbon Inc., SLM Solutions Group, Prodways Group, Formlabs, Renishaw plc, DWS Systems, EnvisionTEC Inc., 3D Systems Inc., and Stratasys Ltd.

In November 2019, Formlabs announced a new wing called Formlabs Dental, dedicated to 3D printing of dental healthcare equipment and implements.

Dental 3D Printing Market Segmentation:

The global dental 3D printing market has been segmented on the basis of product and service, technology, application, end user, and region.

On the basis of product and service, the global dental 3D printing market has been segmented into equipment, materials, and services. The equipment segment has been sub-segmented into dental 3D scanners and dental 3D printers. The materials segment has been sub-segmented into plastic, metal, and other materials.

On the basis of technology, the dental 3D printing market has been segmented into vat photopolymerization, fused deposition modelling (FDM), polyjet technology, selective laser sintering, and other technologies. The vat photopolymerization segment has been further sub-segmented into stereolithography and digital light processing.

The market, by application, has been segmented into prosthodontics, orthodontics, and implantology.

On the basis of end user, the dental 3D printing market has been segmented into dental laboratories, dental hospitals and clinics, dental academic and research institutes.

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/dental-3d-printing-market-6260

Dental 3D Printing Market Regional Analysis:

The Americas holds the dominant share in the global dental 3D printing market, followed by Europe. The strong presence of leading players in 3D printing technology in North America and Europe is the major driver for the dental 3D printing market in these two regions.

Injection Pen Market Opportunities, Comprehensive Analysis, Segmentation, Business Revenue, Application

Injection Pen Market Analysis

The global injection pen market is expected to exhibit a strong 6.5% CAGR over the forecast period from 2018 to 2023, according to the latest market research report from Market Research Future (MRFR). The global injection pen market is mainly driven by the growing prevalence of chronic diseases requiring frequent injections and the growing awareness about the availability and benefits of injection pens over the conventional vial and syringe system. The report profiles the major factors affecting the global injection pen market to pinpoint the major drivers and restraints affecting the market and presents a detailed analysis of how the market is likely to grow over the forecast period.

The growing prevalence of chronic diseases such as diabetes and osteoporosis is likely to drive the global injection pen market over the forecast period. Insulin injections are a major application channel for the global injection pen market and are likely to retain their position as such over the forecast period due to the growing prevalence of diabetes and the immense advantages provided by injection pens in terms of managing the progression of diabetes. Diabetics require a regular administration of insulin injections, which can be cumbersome to handle with the conventional vial and syringe method. The conventional method also requires the patient to visit the hospital for each injection, which may be impractical for some patients. Using an injection pen makes it easier for diabetics to self-manage their disease, making this a key driver for the global injection pen market over the forecast period.

The growing product innovation in injection pens is also likely to be a major driver for the global injection pen market over the forecast period, as the technology to make injection pens safer and more effective is high in demand due to the growing popularity of injection pens. The growing efforts by manufacturers to make the most of the opportunity in the global injection pen market are likely to remain a key driver for the global injection pen market over the forecast period.

Injection Pen Market Segmentation:

The global injection pen market is segmented on the basis of type, product, therapy, distribution channel, end user, and region.

On the basis of type, the injection pen market is classified into disposable injection pens and reusable injection pens.

The global injection pen market is segmented into insulin pens and pen needles on the basis of product.

On the basis of therapy, the injection pen market is segmented into diabetes, growth hormone therapy, fertility, osteoporosis, multiple sclerosis, cardiovascular diseases, rheumatoid arthritis, obesity, Crohn’s disease, cancer, and others. The diabetes segment is further segmented into insulin and GLP-1.

On the basis of distribution channel, the injection pen market is segmented into hospital pharmacies, retail pharmacies, online medical stores, and diabetes clinics.

On the basis of end user, the global injection pen market is segmented into home care and hospitals and clinics.

Injection Pen Market Regional Analysis:

The global injection pen market is segmented by region into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas is likely to remain the leading geographical segment of the global injection pen market over the forecast period due to the widespread adoption of injection pens and the growing popularity of injection pens in the healthcare sector. The growing presence of major market players in the U.S. and Canada is also conducive to steady growth of the injection market in the Americas.

Europe is also a major regional market for injection pen technology and is likely to remain a major revenue generator over the forecast period due to the growing economic burden of diabetes, which has driven the demand for more convenient and effective ways to manage diabetes. The advanced healthcare and medical devices sector in Europe is likely to be a major driver for the injection pen market in the region over the forecast period.

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/injection-pen-market-6146

Injection Pen Market Competitive Analysis:

Leading players in the global injection pen market include Novo Nordisk, Sanofi, Ypsomed, F. Hoffman-La Roche, Owen Mumford, Pfizer, Jiangsu Delfu Medical Device Co. Ltd., Biocon Ltd., Haselmeier, Novartis, Becton Dickinson and Company, AstraZeneca, Merck, and Eli Lilly.

Injection Pen Industry Updates:

In March 2019, Eli Lilly announced the launch of an authorized generic formulation of its Humalog insulin lispro injection in the U.S. at half the price of the conventional formulation.

Medical Ceramics Market Size, Global Trends And Forecast By Regions, Segmentation, Applications

Medical Ceramics Market Overview

The global medical ceramics market is expected to exhibit a strong 6.5% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). The global medical ceramics market has become a major part of the global healthcare sector in recent years due to the rising awareness about the various applications of medical ceramics. This has driven robust growth in the medical ceramics market, with new players joining the market and established players looking to scale up their operations through capacity expansions and collaboration efforts. A detailed review of the competitive landscape of the global medical ceramics market is provided in the report, including profiles of the major players operating in the market.

Medical ceramics are used for structural or supportive purposes in dentistry, orthopedics, cardiovascular disease management and surgeries, and other applications. The strong materials used in medical ceramics are perfect for usage in dental applications, as they are used to produce highly valuable, long-lasting dental caps and crowns, among others. The growing demand for dental crowns, driven by the growing prevalence of plaque and other dental conditions, is likely to be a major driver for the global medical ceramics market over the forecast period. The growing dental healthcare industry in Asia Pacific and other emerging economies is likely to be a key driver for the global medical ceramics market.

Medical ceramics are also widely used in orthopedic applications as a replacement for bone matter. The growing demand for effective bone substitutes in the healthcare sector is likely to be a major driver for the medical ceramics market over the forecast period. Rapid growth in materials research and development is likely to be a key driver for the medical ceramics market, as new materials and production technologies are likely to be developed in the coming years, helping the medical ceramics market achieve smoother operations and higher profit margins. The use of medical ceramics in diagnostic and surgical instruments is also likely to be a key driver for the global medical ceramics market over the forecast period.

Medical Ceramics Market Competitive Analysis:

Leading players in the global medical ceramics market include DePuy Synthes, Morgan Advanced Materials, Nobel Biocare Services AG, 3M ESPE, H. C. Starck GmbH, Kyocera Corporation, Stryker, Straumann, Zimmer Holdings Inc., and CoorsTek Inc.

In October 2019, Lithoz announced that it would display its latest CeraFab family of mahcines designed for high-volume production of high-performance AM ceramics at November’s Formnext.

In July 2019, Neural Analytics Inc., a leading player in developing and selling brain health tracking and management tools and technologies, announced a collaboration with NGK Spark Plug Co., a leading Japanese player in the field of ceramics processing.

Medical Ceramics Market Segmentation:

The global medical ceramics market is segmented on the basis of type, application, end user, and region.

On the basis of type, the medical ceramics market is segmented into bioactive ceramics, bioinert ceramics, piezoceramics, and bioresorbable ceramics. Bioinert ceramics are further sub-segmented into zirconia, alumina, and others. Bioactive ceramics are further sub-segmented into hydroxyapatite and glass ceramics.

On the basis of application, the market is segmented into cardiovascular, dental, orthopedic, surgical instruments, diagnostic instruments, plastic surgery, and others. Dental is further sub-segmented into dental implants, dental crowns and bridges, braces, inlays and onlays, and dental bone grafts and substitutes. Orthopedic is further sub-segmented into joint replacement, fracture fixation, and orthobiologics. Joint replacement is further sub-segmented into knee replacement, hip replacement, shoulder replacement, and others.

On the basis of end user, the market is segmented into specialty centers, hospitals and clinics, and research centers.

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/medical-ceramics-market-5729

Medical Ceramics Market Regional Analysis:

The Americas are a dominant regional market for medical ceramics, accounting for around 42% of the market in 2016. Europe is also a dominant force in the market and accounts for close to half of the rest. The growing geriatric population in these regions is likely to be a key driver for the medical ceramics market. Asia Pacific is also expected to exhibit steady growth in the coming years.

Blood Transfusion Diagnostics Market 2020 Global Trends, Share, Industry Size, Growth, Opportunities And Industry Forecast To 2023

Blood Transfusion Diagnostics Market Overview:

Blood transfusion is a process that ensures safe intravenous transfer of blood or blood products. The process can also allow replacement of blood. Various blood components like red blood cells, white blood cells, platelets, clotting factors and plasma can also be transfused. These components find great application in hospitals during emergencies. The global blood transfusion diagnostics market has been predicted to grow up to USD 2.45 billion in 2023 with a CAGR of 8.2% over the review period of 2017-2023. Market Research Future (MRFR) claims that the global market has the potential to surpass market predictions and ensure better growth for itself.

Various factors, like technological advancements, safe transfer procedures, various chronic diseases, and others can impact the global market. But the process requires proper screening to prohibit any unwanted disease to get transferred. Governments have introduced stringent measures to prohibit such cases from having. Hike in the campaign to promote the process can also be suggested as a good market backup.

Blood Transfusion Diagnostics Market Segmentation:

The global blood transfusion diagnostics market report has been segmented by MRFR for a better understanding of the factors that can impact the market in the coming years. This segmentation has better insights to provide a better direction for the coming years.

Based on the blood product, the global blood transfusion diagnostics market can be segmented into red blood cells, platelets, plasma, albumin, immunoglobulin preparations and other products.

Based on the technology, the blood transfusion diagnostics market comprises western blot, ELISA, nucleic acid amplification, fluorescence assay, rapid test and other technologies. The ELISA segment comprises fluorescence immunoassays (FIA), chemiluminescence immunoassay (CLIA), and colorimetric immunoassay (CI). The Nucleic Acid Amplification segment includes Thermomechanical analysis (TMA) and real-time PCR.

Based on the end-users, the blood transfusion diagnostics market can be segmented into hospitals, clinics, blood banks, and laboratories. The hospitals segment has substantial market coverage as a lot of people opt for this option to undergo the process.

Blood Transfusion Diagnostics Market Regional Analysis:

The Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA) are regions that have been included in the geographical reading of the global blood transfusion diagnostics market. The process eases the identification steps for the growth pockets.

The Americas is known for their high impact on the global blood transfusion diagnostics market. Several factors are working in favor of the growth of the regional blood transfusion diagnostics market, among them increasing adoption of nucleic acid implication test of diagnosis, automation of blood banks and stringent rules for storage & transfusion of blood play integral roles. The growth is exceptionally well in North America where the presence of the U.S. and Canada are playing important roles.

Europe’s growth has base in features that are quite similar to that of the Americas. The market is witnessing substantial hike in the demand for improved diagnostics test, availability of the skilled healthcare professionals and better collaboration with NGO’s, which can be accredited for the growth of the regional market. The APAC market is all set to get the highest growth during the forecast period where Japan would posit itself as the largest market. The market is also expecting strong traction from countries like China and India. These two countries are showing substantial integration of the latest technologies that can impact the regional market and influence their individual outcome.

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/blood-transfusion-diagnostics-market-1126

Blood Transfusion Diagnostics Market Competitive Landscape:

Prominent companies taking part in the global blood transfusion diagnostics market are Roche Diagnostics (Switzerland), Grifols (Spain), Thermo Fisher Scientific, Inc. (U.S.), Immucor (U.S),  bioMérieux (France), Bio-Rad Laboratories, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Siemens Healthineers (Germany), Ortho Clinical Diagnostics, Inc. (U.S.), Ortho Clinical Diagnostics (U.S), Novartis AG (Switzerland), Beckman Coulter, Inc. (U.S.), Diagast (France), Beckman Coulter (U.S), BAG healthcare (Germany),  DiaSorin (Italy), Fujirebio (Belgium), Grifols (Spain), Quidel (U.S), Hologic/Gen-Probe (U.S Abbott Diagnostics (U.S),), Biokit (Spain). MRFR profiled these companies to have their market analyzed in a better way.

Foley Catheters Market Analysis, Share, Size, Trends And Industry Growth

Foley Catheters Market Overview

A foley catheter is commonly known as a flexible urinary drainage tube that passes through the urethra and subsequently into the bladder with the aid of a tiny water-inflated balloon. They technology for the same is improving at a continuous pace and is bringing forward new opportunities in the market. These products are usually recommended by healthcare experts and providers for individuals who suffer from bladder-related issues like urinary incontinence and urinary retention. The rising incidence of urologic diseases across the globe is the primary driver pushing the market growth of foley catheters.

The global foley catheters market was analyzed by Market Research Future (MRFR) and it was projected that a decent CAGR of 7.8% will be attained by the market over the forecast period of 2014 to 2023. The valuation of the foley catheters market was further stated to surpass its previous valuation to reach USD 987.3 million by 2023.

Foley Catheters Market Segmentation

The global foley catheters market has been segmented in terms of type, end-user, and material.

By material, the market includes silicone elastomer coated latex, silicone, silicone elastomer coated latex, latex, polytetrafluoroethylene PTFE (Teflon) coated latex, hydrophilic polymer coated latex, and others. The latex segment holds the largest share in the global market of foley catheters. Whereas, the hydrophilic polymer coated latex segment is anticipated to grow during the forecast period at a notable pace of 8.3%.

By type, the market is segmented into 4-way catheters, 3-way catheters, 2-way catheters, and others. The 2-way catheters segment leads the global market with the largest percentage of share to its name. The segment is anticipated to grow at a considerable pace to attain a revenue worth USD 527.4 by 2023.

By end-users, the market divides into medical research center, hospitals, and ambulatory surgery centers.

Foley Catheters Market Regional Analysis

The global foley catheters market is geographically distributed across the following key regions: Asia Pacific, North America, Europe, and the Rest of the World (RoW).

The North American region is estimated to be the leading contributor for Foley catheters in the coming years. The growth of the regional market can be credited to the large pool of money being invested in research and development activities and increasing product development being made herein. Back in 2016, the market in North America stood at a valuation of USD 228.8 Million and is expected to surpass the same by the end of the ongoing assessment period. The region also includes established healthcare facilities alongside attractive reimbursement policies, which are collectively influencing the growth of the market.

The European region is reported to maintain its second position in the global foley catheters market. This is due to the rising adoption of some of the latest and advanced products as well as technologies in this region. The market is reported to reach a valuation of USD 306.1 million by the end of the forecast period. In Europe, the U.K. is slated to experience the fastest growth percentage, while Germany is expected to dominate the regional market.

The Asia Pacific region holds an important position in the market of foley catheters globally. The regional market is said to experience rapid growth rate in the coming years. The growth of the Asia Pacific market can be attributed to the widespread incidence of various urological diseases and the increasing expenditure in the healthcare sector. Emerging nations like China and India are primed to be higly lucrative areas for the market due to the prevalence of chronic diseases, expanding geriatric population, and accelerating demand for advanced therapies as well as products.

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/foley-catheter-market-922

Foley Catheters Market Competitive Landscape

The global foley catheters market comprises a host of key players. This includes names like Medline Industries Inc. (US), Cook (US), Teleflex (US), B. Braun Melsungen AG (Germany), Coloplast Ltd (Denmark), and Medtronic (Republic of Ireland).

Feminine Hygiene Market Size, Share, Growth, Forecast, Key Findings, Competitive Landscape, Industry Analysis, Segmentation And Trends

Feminine Hygiene Market Analysis

The global feminine hygiene market is growing rapidly over the past few years. Factors such as the rising awareness towards the benefits of feminine hygiene products and the improving economic conditions globally drive the growth of the market. Besides, easy accessibility of the cost-competitive feminine hygiene products and growing awareness of female health and hygiene boosts the growth of the market. The market is estimated to witness significant growth over the assessment period.

According to a renowned research firm – Market Research Future (MRFR), the global feminine hygiene market had created a valuation of over USD 21.96 BN in 2018, which would further appreciate at a CAGR of 7.2% throughout the forecast period (2019 – 2024). In addition to the increasing female population, other factors contributing to the market growth include the growing prevalence of chronic diseases & disorders related to women’s reproductive organs.

Simultaneously, growing numbers of working women populations, especially in developing countries coupled with the increasing awareness of the advantages of women’s care, propel market growth. Furthermore, the rising demand for feminine care products such as tampons and panty liners in developing countries would fuel the growth of the market.

On the other hand, rising side effects associated with some of the feminine hygiene products and allergy cases among women are anticipated to impede the growth of the market. Nevertheless, technological advancements transpired in the manufacturing technics would support the market growth, bettering these products to the core. 

Global Feminine Hygiene Market – Segments

The report is segmented into three dynamics to widen the scope of understanding, 

By Product Type: Sanitary Napkins/Pads, Tampons, Panty Liners, Menstrual Cups, Feminine Hygiene Wash, and others.

By Distribution Channel: Supermarket & Department Stores, Retail Pharmacies, Online Retail Stores, and others.

By Regions: Europe, North America, Asia Pacific, and the Rest-of-the-World (RoW).

Feminine Hygiene Market - Regional Analysis

The Asia Pacific region dominates the global feminine hygiene market with the largest market share. Increasing per-capita disposable income in the middle-income populations has led to rising the purchasing power of women for quality hygiene products. Rapidly developing countries, China and India are driving the APAC feminine hygiene market, majorly. 

Besides, the rising awareness among consumers across the region towards the benefits of feminine hygiene products fosters regional market growth. Moreover, several initiatives taken by the government and the non-government organization in this region are expected to propel the market, increasing the awareness about feminine hygiene products.

North America stands second in the global feminine hygiene market. The market growth attributes to the well-spread awareness among consumers about feminine hygiene and high disposable income. Besides, the presence of major players in the region alongside the high penetration of feminine hygiene products such as tampons, sanitary pads, panty liners, and internal cleansers drives the growth of the regional market. Also, increasing demand for organic and biodegradable products among the increasing working women impacts the regional market growth, positively.

The feminine hygiene market in Europe is expected to grow with a significant CAGR creating a considerable revenue pocket globally. Factors such as the wide access to feminine hygiene products and increasing spending on menstrual products due to the rapid urbanization and improving economic conditions in the region drive market growth. The European feminine hygiene market is expected to grow at a considerable CAGR over the forecast period. 

Feminine Hygiene Market  - Competitive Analysis

The feminine hygiene market appears to be fiercely competitive due to the presence of several well-established players. These players incorporate acquisition, strategic partnership, & technology launch. Based on product differentiation, portfolio, and pricing, these players compete against each other. The competitive strength of these players is dependent on product precision, product pricing, versatility, and product reliability.

Feminine Hygiene Market Major Players: 

Players leading the global feminine hygiene market include Edgewell Personal Care, Procter and Gamble, Unicharm Corporation, Lil-Lets Group Ltd, Kimberly-Clark Corporation, Svenska Cellulosa Aktiebolaget SCA, Ontex International, Johnson & Johnson, Natracare LLC, and Kao Corporation, among others.

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/feminine-hygiene-market-7986

Feminine Hygiene Industry/Innovation/ Related News:

October 05, 2019 ---- The German government announced its plans to reduce the sales tax on feminine hygiene products from 19% to 7% starting in 2020. The decision was based on the campaigns that many women took part in requesting the reduction. The tax reduction would be introduced as part of annual tax amendments for 2020 and go into effect as of January 1, 2020.

The move is a part of growing international resistance to the higher tax rate on feminine hygiene products. Under German tax law, the lower rate of 7% is intended for products necessary for everyday life, while the higher rate of 19% applies to luxury goods. However, in practice, it is not always clear why a specific tax rate is applied. Some German states, like Thuringia and Bremen, have already reduced the tax or eliminated it completely.

Radiology Services Market Global Projection, Developments Status, Analysis, Trends, Strategic Assessment, Research, Size, Share And Global Expansion By 2024

Radiology Services Market Overview

Global radiology services market is growing dramatically, mainly due to the advances in radiology technologies. Rising usages of radiology services such as X-Rays, magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), ultrasound, fusion imaging, and nuclear medicine, to offer accurate diagnosis are fostering the growth of the market. Additionally, factors such as the rising prevalence of chronic disease and demand for minimally invasive procedures are accelerating market growth.

According to Market Research Future (MRFR), in 2018, the global radiology services market had touched a valuation of USD 8,102.51 MN, which is projected to appreciate further at 10.5% CAGR during the forecast period (2019–2024). Increasing healthcare expenditure and the emergence of thin client 3D viewers are expected to drive the growth of the market exponentially. Moreover, rising R&D investments and strategies adopted by the top players operating in the market are contributing to the market growth, bringing about innovations and new product launches.

Increasing efforts of regulatory agencies to reduce the regulatory burden on the medical device industry is further supporting the market growth excellently. For instance, in June 2018, the FDA reclassified some types of radiology image software analyzers from class III to class II devices for radiograph lung nodules, mammography breast cancer, and ultrasound breast lesions. Moreover, government initiatives to promote radiology technology as the best option for early diagnosis in the multitude of chronic daises propel the growth of the market.

On the other hand, risks associated with high radiation exposure could hamper market growth during the assessment period. Nevertheless, the availability of advanced radiology technologies would support the market growth throughout the review period, providing ample scope of the growth opportunities. Also, substantial R&D investments to bring about more novelty and betterments in imaging techniques are anticipated to boost the market growth profoundly. 

Global Radiology Services Market – Segments

The analysis is segmented into five main dynamics to widen the scope of understanding,

By Product Type: Stationary Digital Radiology Systems (stationary ceiling-mounted and floor-to-ceiling mounted system) and Portable Digital Radiology Systems.

By Application: Chest Imaging, Cardiovascular Imaging, Dental Imaging, Orthopedic Imaging, Mammography Imaging, and others.

By Technology: Computed Radiology, Direct Digital Radiology, and others.

By End User: Hospitals, Diagnostic Centers, and others.

By Regions: Americas, Europe, Asia-Pacific, Middle East & Africa, and Rest-of-the-World

Based on the product type, the market is segmented into stationary digital and portable digital radiology systems. Out of these, the stationary digital radiology segment accounts for a substantial market share, owing to the widespread application of stationary systems in hospitals to minimize harmful radiation exposure. On the other hand, the portable digital radiology segment is growing at the highest CAGR as the low-cost, lightweight, portable devices can offer exceptional care, especially in the ICUs, emergency departments, and neonatal intensive care units (NICU) due to their capability of performing complex computational tasks.

Global Radiology Services Market – Geographical Analysis

North America dominates the global radiology services market with the rising funding & investments made in advancing healthcare infrastructures by the governments and private entities. Besides, factors such as the increasing prevalence of chronic diseases, alongside the rising geriatric population, drive the regional market growth, creating a large patient pool.

Undoubtedly, advances in radiology technology and well-spread awareness among the population are the two major driving forces leading the growth in the radiology services market in North America. Also, the US radiology services market, heading with substantial healthcare expenditures, supports the regional market majorly.

Europe stands second in the global radiology services market owing to the increasing number of cancer patients in the region. Additionally, government funding and support to develop the healthcare sector and to drive R&D in the radiology field impact the market growth positively. Moreover, factors such as favorable reimbursement policies, the proliferation of advanced treatment facilities, and the availability of skilled medical professionals in the region are contributing to the growth of the European radiology services market.

The Asia Pacific region is emerging as a promising market for radiology services. The increasing prevalence of cancer and rising investments & expansions by the global market players are substantiating the growth of the regional market. Besides, factors such as spreading awareness among people and the availability of radiology services in the region foster the growth of the market. 

Global Radiology Services Market – Competitive Landscape

Fiercely competitive, the radiology services market appears highly fragmented due to the presence of many large & small-scale players. These players invest substantially to form strategic partnerships and collaborations to gain a larger competitive advantage. They also invest in driving RD activities and in meeting their expansion plans. Through R&D, they drive technology launch, and to expand their global footprints, they acquire promising companies from emerging regions. 

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/radiology-services-market-7904

Radiology Services Market  Major Players:

Players leading the global radiology services market include Cybernet Medical Corporation, 4ways Healthcare Limited, Everlight Radiology, Medica Reporting Ltd., Global Diagnostics, Onrad, Inc., RamSoft Inc., Radisphere National Radiology Group Inc., Siemens Healthcare, Telemedicine Clinic, Telediagnostics Services Pvt. Ltd., Virtual Radiology (vRAD), and Teleradiology Solutions Inc., among others. 

Radiology Services Industry/ Innovation/Related News:

December 19, 2019 ---- Fujifilm (Japan), a leading global diagnostic imaging and information systems company, announced the acquisition of a Japanese Hitachi Diagnostic Imaging Business. The deal valuing at approximately USD 1.6 BN will enable these two radiology companies to bring about a new entity that could compete with larger organizations to capture an expanded footprint & market share. This move aligns with Fujifilm’s ongoing efforts to expand its medical systems business, including platforms medical & nursing data, and new AI & analytics services.